Clinical management of borderline ovarian tumors

Expert Review of Anticancer Therapy
F TrillschA du Bois

Abstract

Borderline ovarian tumors (BOTs) are epithelial tumors of the ovaries characterized by cellular proliferation and nuclear atypia but without an infiltrative growth pattern. As they frequently affect younger patients the clinical management is complicated by considerations such as preserving fertility and reducing postoperative morbidity. Over the past several decades surgical therapy has shifted from a radical approach to more conservative treatment. There are various modes of surgery applied to the patients. All these developments have to be considered from an oncologic standpoint as BOTs represent a potentially malignant disease. Oncologic safety, as well as patients' desires and expectations, have to be balanced to reach the most appropriate treatment for BOTs. For this reason current literature will be discussed in this review to give a thorough overview of this topic and to develop recommendations for the surgical management of these patients. Open questions will be identified to elaborate the need for future surveys and research.

References

Jul 7, 2000·Seminars in Surgical Oncology·C G TropéA Makar
Nov 1, 1993·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J. KaernE.O. Pettersen
Jan 5, 2002·Obstetrics and Gynecology·Barbara M ButtinDavid G Mutch
Nov 5, 2002·Best Practice & Research. Clinical Obstetrics & Gynaecology·David M Gershenson
Nov 15, 2002·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Seung Eun JungSeong Tai Hahn
Mar 22, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P MoriceD Castaigne
May 27, 2003·The American Journal of Surgical Pathology·Ann E Smith SehdevRobert J Kurman
Dec 12, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Jeffrey D SeidmanBrigitte M Ronnett
Jun 24, 2004·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Robin L ParkerC Blake Gilks
Aug 4, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sophie CamatteDamienne Castaigne
Aug 7, 2004·Human Pathology·Steven G SilverbergRobert H Young
Aug 7, 2004·Human Pathology·Mark E ShermanJeffrey D Seidman
Jan 18, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R FauvetE Daraï
Mar 12, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·William R Hart
Mar 26, 2005·Gynecologic Oncology·Xavier DeffieuxDamienne Castaigne
Jul 13, 2005·Gynecologic Oncology·Ali AyhanTurkan Kucukali
Jul 27, 2005·Gynecologic Oncology·Patrice DesfeuxFabrice Lécuru
Aug 24, 2005·Histopathology·R J KurmanI-M Shih
Oct 12, 2005·Gynecologic Oncology·Raffaele TinelliAntonio Malvasi
Nov 26, 2005·Gynecologic Oncology·Cesare RomagnoloTiziano Maggino
Dec 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P Morice
Feb 24, 2006·Annals of Surgical Oncology·Christophe PonceletEmile Daraï
May 2, 2006·Fertility and Sterility·Laurent J SalomonPhilippe Morice
May 11, 2006·British Journal of Cancer·Y YokoyamaH Mizunuma
Aug 9, 2006·Current Opinion in Oncology·Isabelle CadronIgnace Vergote

❮ Previous
Next ❯

Citations

Oct 2, 2012·The Oncologist·Daniela FischerovaDavid Cibula
Apr 17, 2014·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·D BasaranK Yuce
Aug 14, 2012·Lancet·Fabian TrillschSven Mahner
Jul 11, 2013·Journal of Ovarian Research·Fabian TrillschSven Mahner
Nov 23, 2011·Orvosi hetilap·Zoltán LangmárJózsef Gábor Joó
Feb 11, 2012·Best Practice & Research. Clinical Obstetrics & Gynaecology·Claes Göran TropéBen Davidson
May 4, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A du BoisP Harter
May 12, 2016·Gynecologic Oncology·Nikoline Marie Schou KarlsenClaus Høgdall
Jul 23, 2016·American Journal of Obstetrics and Gynecology·Dorella FranchiAntonia Carla Testa
Jul 29, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Eveline VancraeynestIgnace Vergote
Sep 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Donata RohsbachSven Mahner
Nov 25, 2016·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·B P JonesJ Yazbek
Aug 2, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Benjamin P JonesJoseph Yazbek
Jul 18, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Annamaria FerreroPierandrea De Iaco
Aug 8, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Zibi MarchockiTaymaa May
Sep 26, 2015·Journal of Gynecologic Oncology·Seok Ju SeongTaejong Song
Mar 30, 2018·Case Reports in Surgery·Hugo Palma RiosPedro Leão
Jan 20, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Irini MessiniKitty Pavlakis
May 6, 2021·Archives of Gynecology and Obstetrics·Ailyn M Vidal UrbinatiDorella Franchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved